Skip to main content
. 2023 Mar 13;18(1):20230666. doi: 10.1515/med-2023-0666

Figure 6.

Figure 6

LANCL1-AS1 overexpression inhibits tumorigenesis of NSCLC in vivo. (a) BALB/c nude mice were implanted with H460 cells stably expressing Lv-pcDNA3.1 or Lv-LANCL1-AS1. n = 5 per group. (b) Tumor volumes were detected every 3 days. (c) Tumor weight was measured on the 18th day. (d) Western blotting for examining levels of angiogenesis-related proteins in tumors. (e–g) RT-qPCR analysis for evaluating LANCL1-AS1, miR-3680-3p, and GMFG expression in tumor tissues. ** p < 0.01, *** p < 0.001.